A new study published in Drug and Alcohol Review has revealed critical insights into the challenges and risks faced by women who use anabolic-androgenic steroids (AAS).
CEB-01 by Cebiotex for Nerve Sheath Tumor: Likelihood of Approval
CEB-01 is under clinical development by Cebiotex and currently in Phase I for Nerve Sheath Tumor.